SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

TactiCath

Contact Force Ablation Catheter, Sensor Enabled

HeaderBanner
Product Features

Product Features

The TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ offers the following features:*

  • Force sensor at the distal catheter tip
  • Fiber optic technology for optimal stability during contact force measurement
  • D, F, and J uni-directional and D-D, D-F, F-F, F-J, and J-J bi-directional deflectable curves
  • 2-2-2 electrode spacing for standard electrogram recordings
  • Compatibility with steerable sheaths (such as the Agilis™ NxT introducer), resulting in increased contact force1
  • Minimal influence of temperature for stable contact force measurement

*Requires TactiSys™ Quartz hardware system and accessories

Unique advantages of the TactiCath Contact Force Ablation Catheter, Sensor Enabled and the TactyiSys Quartz System
 

Designed for seamless integration, the TactiSys Quartz system is a plug-and-play system that eliminates the need for thermal calibrations.

TactiSys also offers:

  • High-precision contact force measurements with 1 g resolution
  • Real-time feedback: Fast 50 Hz (20 ms) sample rate
  • No impact on the force measurement accuracy from nearby ferrous materials (braiding of sheath, nearby circular mapping catheters)
TactiCath Contact Force Ablation Catheter, Sensor Enabled

FORCE TIME INTEGRAL (FTI INDEX)
 

The FTI™ index is a clinically validated proprietary index calculating force over time. FTI index is incorporated into the TactiCath Quartz contact force sensing ablation catheter labeling.2

Line graph showing force time interval by ablation duration. FTI equals contact force times time.

LESION INDEX (LSI)
 

The LSI (Lesion Index) is a proprietary index combining contact force, radiofrequency (RF) application duration and RF current. This parameter was designed to model both the resistive heating and thermal conduction stages of lesion formation.

Visual depiction of lesion formation.
Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

References

  1. Mansour, M. (2014, May). TOCCASTAR: Preliminary results of the first prospective randomized study of a contact force sensing ablation catheter for the treatment of paroxysmal AF. Presented at the meeting of the Heart Rhythm Society, San Francisco, CA.
  2. Reddy, V., Shah, D., Kautzner, J., Schmidt, B., Saoudi, N., Herrera, C., … Kuck, K. H. (2012). The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm, 9(11), 1789-1795. https://dx.doi.org/10.1016/j.hrthm.2012.07.016

MAT-2103110 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0